Copyright Reports & Markets. All rights reserved.

Global Bioresorbable Scaffolds Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Bioresorbable Scaffolds Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Peripheral Bioabsorbable Stents
    • 1.3.3 Coronary Bioabsorbable Stents
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Bioresorbable Scaffolds Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospitals and Clinics
    • 1.4.3 Cardiac Catheterization Laboratory
    • 1.4.4 Other
  • 1.5 Global Bioresorbable Scaffolds Market Size & Forecast
    • 1.5.1 Global Bioresorbable Scaffolds Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Bioresorbable Scaffolds Sales Quantity (2021-2032)
    • 1.5.3 Global Bioresorbable Scaffolds Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Abbott
    • 2.1.1 Abbott Details
    • 2.1.2 Abbott Major Business
    • 2.1.3 Abbott Bioresorbable Scaffolds Product and Services
    • 2.1.4 Abbott Bioresorbable Scaffolds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Abbott Recent Developments/Updates
  • 2.2 Boston Scientific
    • 2.2.1 Boston Scientific Details
    • 2.2.2 Boston Scientific Major Business
    • 2.2.3 Boston Scientific Bioresorbable Scaffolds Product and Services
    • 2.2.4 Boston Scientific Bioresorbable Scaffolds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Boston Scientific Recent Developments/Updates
  • 2.3 Wego Healthcare
    • 2.3.1 Wego Healthcare Details
    • 2.3.2 Wego Healthcare Major Business
    • 2.3.3 Wego Healthcare Bioresorbable Scaffolds Product and Services
    • 2.3.4 Wego Healthcare Bioresorbable Scaffolds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Wego Healthcare Recent Developments/Updates
  • 2.4 Elixir
    • 2.4.1 Elixir Details
    • 2.4.2 Elixir Major Business
    • 2.4.3 Elixir Bioresorbable Scaffolds Product and Services
    • 2.4.4 Elixir Bioresorbable Scaffolds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Elixir Recent Developments/Updates
  • 2.5 Arterial Remodeling Technologies
    • 2.5.1 Arterial Remodeling Technologies Details
    • 2.5.2 Arterial Remodeling Technologies Major Business
    • 2.5.3 Arterial Remodeling Technologies Bioresorbable Scaffolds Product and Services
    • 2.5.4 Arterial Remodeling Technologies Bioresorbable Scaffolds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Arterial Remodeling Technologies Recent Developments/Updates
  • 2.6 Lepu Medical
    • 2.6.1 Lepu Medical Details
    • 2.6.2 Lepu Medical Major Business
    • 2.6.3 Lepu Medical Bioresorbable Scaffolds Product and Services
    • 2.6.4 Lepu Medical Bioresorbable Scaffolds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Lepu Medical Recent Developments/Updates
  • 2.7 Huaan Bio
    • 2.7.1 Huaan Bio Details
    • 2.7.2 Huaan Bio Major Business
    • 2.7.3 Huaan Bio Bioresorbable Scaffolds Product and Services
    • 2.7.4 Huaan Bio Bioresorbable Scaffolds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Huaan Bio Recent Developments/Updates
  • 2.8 ELLA-CS
    • 2.8.1 ELLA-CS Details
    • 2.8.2 ELLA-CS Major Business
    • 2.8.3 ELLA-CS Bioresorbable Scaffolds Product and Services
    • 2.8.4 ELLA-CS Bioresorbable Scaffolds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 ELLA-CS Recent Developments/Updates

3 Competitive Environment: Bioresorbable Scaffolds by Manufacturer

  • 3.1 Global Bioresorbable Scaffolds Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Bioresorbable Scaffolds Revenue by Manufacturer (2021-2026)
  • 3.3 Global Bioresorbable Scaffolds Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Bioresorbable Scaffolds by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Bioresorbable Scaffolds Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Bioresorbable Scaffolds Manufacturer Market Share in 2025
  • 3.5 Bioresorbable Scaffolds Market: Overall Company Footprint Analysis
    • 3.5.1 Bioresorbable Scaffolds Market: Region Footprint
    • 3.5.2 Bioresorbable Scaffolds Market: Company Product Type Footprint
    • 3.5.3 Bioresorbable Scaffolds Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Bioresorbable Scaffolds Market Size by Region
    • 4.1.1 Global Bioresorbable Scaffolds Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Bioresorbable Scaffolds Consumption Value by Region (2021-2032)
    • 4.1.3 Global Bioresorbable Scaffolds Average Price by Region (2021-2032)
  • 4.2 North America Bioresorbable Scaffolds Consumption Value (2021-2032)
  • 4.3 Europe Bioresorbable Scaffolds Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Bioresorbable Scaffolds Consumption Value (2021-2032)
  • 4.5 South America Bioresorbable Scaffolds Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Bioresorbable Scaffolds Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Bioresorbable Scaffolds Sales Quantity by Type (2021-2032)
  • 5.2 Global Bioresorbable Scaffolds Consumption Value by Type (2021-2032)
  • 5.3 Global Bioresorbable Scaffolds Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Bioresorbable Scaffolds Sales Quantity by Application (2021-2032)
  • 6.2 Global Bioresorbable Scaffolds Consumption Value by Application (2021-2032)
  • 6.3 Global Bioresorbable Scaffolds Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Bioresorbable Scaffolds Sales Quantity by Type (2021-2032)
  • 7.2 North America Bioresorbable Scaffolds Sales Quantity by Application (2021-2032)
  • 7.3 North America Bioresorbable Scaffolds Market Size by Country
    • 7.3.1 North America Bioresorbable Scaffolds Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Bioresorbable Scaffolds Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Bioresorbable Scaffolds Sales Quantity by Type (2021-2032)
  • 8.2 Europe Bioresorbable Scaffolds Sales Quantity by Application (2021-2032)
  • 8.3 Europe Bioresorbable Scaffolds Market Size by Country
    • 8.3.1 Europe Bioresorbable Scaffolds Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Bioresorbable Scaffolds Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Bioresorbable Scaffolds Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Bioresorbable Scaffolds Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Bioresorbable Scaffolds Market Size by Region
    • 9.3.1 Asia-Pacific Bioresorbable Scaffolds Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Bioresorbable Scaffolds Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Bioresorbable Scaffolds Sales Quantity by Type (2021-2032)
  • 10.2 South America Bioresorbable Scaffolds Sales Quantity by Application (2021-2032)
  • 10.3 South America Bioresorbable Scaffolds Market Size by Country
    • 10.3.1 South America Bioresorbable Scaffolds Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Bioresorbable Scaffolds Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Bioresorbable Scaffolds Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Bioresorbable Scaffolds Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Bioresorbable Scaffolds Market Size by Country
    • 11.3.1 Middle East & Africa Bioresorbable Scaffolds Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Bioresorbable Scaffolds Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Bioresorbable Scaffolds Market Drivers
  • 12.2 Bioresorbable Scaffolds Market Restraints
  • 12.3 Bioresorbable Scaffolds Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Bioresorbable Scaffolds and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Bioresorbable Scaffolds
  • 13.3 Bioresorbable Scaffolds Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Bioresorbable Scaffolds Typical Distributors
  • 14.3 Bioresorbable Scaffolds Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Bioresorbable Scaffolds market size was valued at US$ 858 million in 2025 and is forecast to a readjusted size of US$ 2150 million by 2032 with a CAGR of 14.2% during review period.
    Bioresorbable Scaffolds are an advanced category of interventional devices designed for the treatment of vascular stenosis through minimally invasive procedures. Unlike conventional metallic stents that remain permanently in the body, these scaffolds are made from biodegradable materials such as poly-L-lactic acid (PLLA), magnesium alloys, or zinc alloys. Once implanted, they provide mechanical support during the healing phase and then gradually degrade, eventually being completely absorbed by the body. This process reduces long-term complications like late restenosis or thrombosis and embodies a comprehensive “support–degradation–repair” therapeutic paradigm. Combining material science, tissue engineering, and precision medicine, bioresorbable scaffolds represent a transformative shift toward temporary, physiology-driven vascular restoration—especially valuable for younger patients and those with limited tolerance to permanent implants. They are emerging as a strategic focus in next-generation interventional therapies.In 2024, global Bioresorbable Scaffolds production reached approximately 378 k units, with an average global market price of around US$ 2000 per unit
    The bioresorbable scaffold market is entering a new phase of multidimensional growth. On one front, global interventional cardiology is shifting toward the concept of "physiological restoration," accelerating the transition from permanent metallic implants to biodegradable scaffolding solutions. Leading device manufacturers are driving commercialization of magnesium and PLLA-based platforms, while regulatory bodies in several countries have introduced fast-track approval pathways for such innovations. Simultaneously, national reimbursement reforms, centralized procurement mechanisms, and rising enthusiasm from tertiary hospitals are creating fertile ground for large-scale adoption across coronary, peripheral, and pediatric indications. As indications expand, local players emerge, and physician education deepens, the commercial potential of this segment is rapidly unlocking.
    Despite its clinical promise, the bioresorbable scaffold industry faces structural hurdles. Early-generation products revealed limitations in long-term outcomes, such as insufficient mechanical durability and unpredictable degradation behavior, raising concerns about sustained efficacy. The development process is lengthy and capital-intensive, with extensive clinical validation required for market entry. Reimbursement policies remain fragmented or absent in many regions, increasing hesitancy among hospitals and physicians. Together, these factors pose dual challenges to enterprise cash flows and market cultivation strategies.
    There is growing clinical interest in non-permanent implants, especially among younger high-risk patients and those with chronic conditions, who prefer therapies with fewer long-term complications and no residual implant. As interventional treatment expands into structural heart disease, neurovascular therapy, and peripheral vascular reconstruction, more specialty and research-oriented hospitals are engaging in early clinical use. In China, several leading hospitals are collaborating with manufacturers on real-world studies (RWS), which is expected to boost physician confidence and facilitate a transition from pilot usage to standardized procurement across the healthcare system.
    This report is a detailed and comprehensive analysis for global Bioresorbable Scaffolds market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Bioresorbable Scaffolds market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Bioresorbable Scaffolds market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Bioresorbable Scaffolds market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Bioresorbable Scaffolds market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Bioresorbable Scaffolds
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Bioresorbable Scaffolds market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Boston Scientific, Wego Healthcare, Elixir, Arterial Remodeling Technologies, Lepu Medical, Huaan Bio, ELLA-CS, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Bioresorbable Scaffolds market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Peripheral Bioabsorbable Stents
    Coronary Bioabsorbable Stents
    Market segment by Application
    Hospitals and Clinics
    Cardiac Catheterization Laboratory
    Other
    Major players covered
    Abbott
    Boston Scientific
    Wego Healthcare
    Elixir
    Arterial Remodeling Technologies
    Lepu Medical
    Huaan Bio
    ELLA-CS
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Bioresorbable Scaffolds product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Bioresorbable Scaffolds, with price, sales quantity, revenue, and global market share of Bioresorbable Scaffolds from 2021 to 2026.
    Chapter 3, the Bioresorbable Scaffolds competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Bioresorbable Scaffolds breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Bioresorbable Scaffolds market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Bioresorbable Scaffolds.
    Chapter 14 and 15, to describe Bioresorbable Scaffolds sales channel, distributors, customers, research findings and conclusion.

    Buy now